Bone Biologics Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BBLG | BRTX | CLGN | CELZ | FBLG | BMEA | |
|---|---|---|---|---|---|---|
| Market cap | 1.18M | 2.09M | 12.18M | 4.95M | 6.86M | 44.24M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.6 | -0.1 | -10.8 | -0.7 | -0.3 | -0.7 |
| Price/book | 0.2 | 0.6 | 2.1 | 0.5 | 1.3 | 3.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −82.39% | −94.93% | −80.60% | −78.05% | −85.54% | −52.92% |
| Today | −1.81% | +2.03% | +2.92% | −3.21% | −2.17% | −1.91% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BBLG news ›MacroGenics (MGNX) director Kuriakose received 44,000 Stock Option (right to buy)
Director Emil granted 44,000 stock options at $2.40 strike and 7,500 RSUs; routine director compensation, no open-market buy. Plus members following MGNX got this by push and email at 16:32:31 ET - 0.9s after publication. Emil Kuriakose…
Minerva Neurosciences Director Inderjit Kaul Granted 2,328 Stock Options with Milestone-Based Vesting
Tronox Announces $0.05 Quarterly Dividend Payable January 15, 2027 On November 3, 2026, Director Inderjit Kaul submitted a Form 4 to the SEC revealing the receipt of a stock option to acquire 2,328 shares of Minerva Neurosciences, Inc.…
Sherwin-Williams grants Jorgenrud 12,055 stock options
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing Bloom Energy Reports Record Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance WD Reports Fiscal First Quarter…
Sherwin Williams grants Davie 7,000 stock options
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing Bloom Energy Reports Record Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance WD Reports Fiscal First Quarter…
Pulsenmore grants David Woods 6,886 stock options
An initial 25% becomes exercisable October 6, 2027; the rest follows in 12 equal quarterly installments, subject to continued service. Expiry is in 2033. Pulsenmore grants David Woods 6,886 stock options The grant's first 25% becomes…
Medpace EVP Burwig exercises options for 3,000 shares
VivoPower Signs Definitive Heads of Agreement with Open Innovation AI to Develop Secure Sovereign AI Data Centers Across the Nordics, Mainland Europe, the GCC and selective countries in Asia BioCryst Announces U.S. FDA Approval of…
Exozymes grants director Rayo 25,000 stock options
A director receives 25,000 Exozymes (EXOZ) stock options with a $6.28 exercise price. Stock Titan Exozymes grants director Rayo 25,000 stock options The options vest over twelve quarterly installments through September 30, 2029, subject to…
CG Oncology grants Isabel Kalofonos 92,000 stock options
CG Oncology (NASDAQ: CGON) is a late-stage biopharma company developing cretostimogene, an intravesical oncolytic immunotherapy for non-muscle invasive bladder cancer. - [Form 4] CG Oncology, Inc. Insider Trading Activity CG Oncology…
Algorhythm Holdings interim CFO receives stock options
Algorhythm Holdings, Inc. (NASDAQ: RIME) is an AI logistics company built around SemiCab’s Collaborative Transportation Platform and Apex SaaS freight orchestration. - [Form 3] Algorhythm Holdings, Inc. Initial Statement of Beneficial…
CalciMedica director Guerard gets 20,000-share option
Frederic Guerard's October 1, 2026 award vests in monthly installments, fully vesting at the 2027 annual meeting. The option expires September 30, 2036. CalciMedica director Guerard gets 20,000-share option The option's monthly vesting…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net16
- kalkinemedia.com1
- quantisnow.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 18 articles, not a forecast.